[[Picamilon]]

CATEGORIES: Anxiolytics, Nootropics, Nicotinamides, GABA analogues

Picamilon (also known as nicotinoyl-GABA, pycamilon, and pikamilon) is a dietary supplement formed by combining niacin with GABA. It was developed in the Soviet Union in 1969 by the All-Union Vitamins Scientific Research Institute[tpl]cite journal | author = Kopelevich VM, Gunar VI | title =  Some approaches to the directed search for new drugs based on nicotinic acid | journal = Pharmaceutical Chemistry Journal | volume = 33 | issue = 4 | pages = 177–187 |date=April 1999 | pmid =  | doi = 10.1007/BF02509934 | url = http://www.springerlink.com/content/r8430r0l4x596027/ [/tpl][tpl]cite journal|author=Kopelevich VM, Shmuylovichem LM, Trubnikov VI[/tpl][tpl]full|date=February 2010[/tpl] and further studied in both Russia[tpl]cite journal | author = Mirzoian RS, Gan'shina TS | title = new cerebrovascular preparation pikamilon | language = Russian | journal = Farmakologiia i toksikologiia | volume = 52 | issue = 1 | pages = 23–6 | year = 1989 | pmid = 2707413 | doi = | issn = [/tpl] and Japan as a prodrug of GABA.[tpl]cite journal | author = Matsuyama K, Yamashita C, Noda A, Goto S, Noda H, Ichimaru Y, Gomita Y | title = Evaluation of isonicotinoyl-gamma-aminobutyric acid (GABA) and nicotinoyl-GABA as pro-drugs of GABA | journal = Chem. Pharm. Bull. | volume = 32 | issue = 10 | pages = 4089–95 |date=October 1984 | pmid = 6529802 | doi = | url = http://www.journalarchive.jst.go.jp/english/jnlabstract_en.php?cdjournal=cpb1958&cdvol=32&noissue=10&startpage=4089 [/tpl]
Picamilon is sold in the United States as a dietary supplement, while in Russia it is sold as a prescription drug. The rights to the drug belong to the Russian pharmaceutical company NPK ECHO ("НПК ЭХО").

==Mechanism of action and potential therapeutic applications==

Picamilon is able to cross the blood–brain barrier[tpl]cite journal | author = Dorofeev BF, Kholodov LE | title = pharmacokinetics in animals | language = Russian | journal = Farmakologiia i toksikologiia | volume = 54 | issue = 2 | pages = 66–9 | year = 1991 | pmid = 1884802 | doi = | issn = [/tpl] and then is hydrolyzed into GABA and niacin.[tpl]fix |link=Wikipedia:Citation needed#Citation needed |text=citation needed |class=Template-Fact [/tpl] The released GABA in theory would activate GABA receptors potentially producing an anxiolytic response.[tpl]cite journal | author = Shephard RA | title = Behavioral effects of GABA agonists in relation to anxiety and benzodiazepine action | journal = Life Sci. | volume = 40 | issue = 25 | pages = 2429–36 |date=June 1987 | pmid = 2884549 | doi = 10.1016/0024-3205(87)90758-2| url =  [/tpl] The second released component, niacin acts as a strong vasodilator,[tpl]cite journal | author = Gille A, Bodor ET, Ahmed K, Offermanns S | title = Nicotinic acid: pharmacological effects and mechanisms of action | journal = Annu. Rev. Pharmacol. Toxicol. | volume = 48 | issue = | pages = 79–106 | year = 2008 | pmid = 17705685 | doi = 10.1146/annurev.pharmtox.48.113006.094746 | url =  [/tpl] which might be useful for the treatment of migraine headaches.[tpl]cite journal | author = Pukhal'skaia TG, Maĭsov NI, Mirzoian RS | title = effect of antimigraine preparations on serotonin transport in the brain synaptosomes of rats | language = Russian | journal = Farmakol Toksikol | volume = 52 | issue = 6 | pages = 39–43 | year = 1989 | pmid = 2625145 | doi = | url = | issn = [/tpl][tpl]cite journal | author = Prousky J, Seely D | title = The treatment of migraines and tension-type headaches with intravenous and oral niacin (nicotinic acid): systematic review of the literature | journal = Nutr J | volume = 4 | issue = | pages = 3 | year = 2005 | pmid = 15673472 | doi = 10.1186/1475-2891-4-3 | url = | pmc = 548511  [/tpl]

==Medical use in Russia==

In Russia, Picamilon is used for treatment of these illness.[ref]
  
</ref> 

==References==

==External links==


